Lobbying registration dated 2026-04-02
Registrant: Martin Arès
Client: Apotex Inc.
Targeted institutions:
Public Services and Procurement Canada (PSPC)
Prime Minister's Office (PMO)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Global Affairs Canada (GAC)
Public Health Agency of Canada (PHAC)
Patented Medicine Prices Review Board (PMPRB)
Immigration, Refugees and Citizenship Canada (IRCC)
Health Canada (HC)
Government funding received:
Lobbying activity details:
Pharmaceutical research & development -support for R&D in Canada.
Pharmaceutical policy: Ongoing interactions related to increased and sustainable utilization of cost-saving generic and biosimilar medicines, and a predictable and viable business environment for generic medicines.
Domestic pharmaceutical manufacturing: trade, tariffs, and sustainability of domestic manufacturing.